Boston Partners Sells 717,384 Shares of Humana Inc. $HUM

Boston Partners reduced its holdings in shares of Humana Inc. (NYSE:HUM) by 98.6% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,200 shares of the insurance provider’s stock after selling 717,384 shares during the period. Boston Partners’ holdings in Humana were worth $2,494,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in HUM. Cary Street Partners Investment Advisory LLC increased its holdings in Humana by 63.9% in the 1st quarter. Cary Street Partners Investment Advisory LLC now owns 118 shares of the insurance provider’s stock worth $31,000 after buying an additional 46 shares during the period. Zions Bancorporation National Association UT acquired a new position in shares of Humana during the first quarter valued at approximately $37,000. AlphaCore Capital LLC purchased a new stake in Humana during the 2nd quarter valued at about $39,000. CVA Family Office LLC grew its holdings in shares of Humana by 63.4% in the second quarter. CVA Family Office LLC now owns 219 shares of the insurance provider’s stock valued at $54,000 after purchasing an additional 85 shares during the period. Finally, Traub Capital Management LLC acquired a new position in shares of Humana in the 2nd quarter valued at $61,000. Institutional investors and hedge funds own 92.38% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on the stock. Wolfe Research dropped their price objective on shares of Humana from $313.00 to $300.00 and set an “outperform” rating for the company in a report on Thursday, November 20th. Bank of America increased their price target on shares of Humana from $280.00 to $300.00 and gave the stock a “neutral” rating in a report on Friday, October 10th. The Goldman Sachs Group lowered their price objective on shares of Humana from $235.00 to $215.00 and set a “sell” rating on the stock in a research note on Monday, November 24th. Royal Bank Of Canada lifted their price objective on Humana from $283.00 to $322.00 and gave the stock an “outperform” rating in a research report on Thursday, August 21st. Finally, Weiss Ratings reiterated a “sell (d+)” rating on shares of Humana in a research report on Wednesday, October 8th. Eight research analysts have rated the stock with a Buy rating, nine have given a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $295.94.

Humana Stock Performance

Humana stock opened at $245.77 on Friday. The stock’s 50 day moving average price is $263.19 and its 200 day moving average price is $256.85. The firm has a market capitalization of $29.56 billion, a PE ratio of 18.86, a price-to-earnings-growth ratio of 1.71 and a beta of 0.42. Humana Inc. has a one year low of $206.87 and a one year high of $315.35. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.95 and a current ratio of 1.95.

Humana (NYSE:HUM) last released its quarterly earnings results on Wednesday, November 5th. The insurance provider reported $3.24 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.95 by $0.29. Humana had a net margin of 1.28% and a return on equity of 13.67%. The firm had revenue of $32.65 billion for the quarter, compared to the consensus estimate of $31.99 billion. During the same quarter in the previous year, the firm posted $4.16 EPS. The firm’s quarterly revenue was up 11.1% on a year-over-year basis. As a group, sell-side analysts expect that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, January 30th. Stockholders of record on Friday, December 26th will be given a $0.885 dividend. The ex-dividend date of this dividend is Friday, December 26th. This represents a $3.54 annualized dividend and a dividend yield of 1.4%. Humana’s payout ratio is presently 33.18%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.